Topic: MS

3-month disability progression reduced with fingolimod

April 13, 2011  

B cell drug set to enter phase III testing

March 30, 2011  

Dalfampridine may improve walking ability: phase III results

March 9, 2011  

Vitamin D and UV exposure during pregnancy/postpartum period

January 26, 2011  

EDSS may underrepresent progression

January 12, 2011  

Demyelination reported following HPV vaccination

October 18, 2010  

Need for early, aggressive treatment in RRMS

October 18, 2010  

New data on fingolimod in RRMS

October 18, 2010  

Treatment discontinuations common in CIS

October 15, 2010  

Switching to fingolimod: TRANSFORMS extension study results

October 15, 2010